Summary of Purpose
The last marketed thrombectomy devices, named stentretriever, permit a better and faster recanalization in patient with a stroke. The REVIVETM SE is a device designed to restore the brain perfusion in patient with an intracranial artery occlusion. The REVIVETM Se device is not widely use in Europe and in France. The objective of this study is to assess the interest of using this device in the standard care of...Read More →
The following dates are available for this trial. Trial information last updated on 22 February 2018.
|1 May 2018||16 Nov 2016||1 Dec 2018||1 Dec 2018||1 Feb 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|